See All Slides - tctmd.com

Slides

Presentation THT Abstracts 2025

Bioelectrical Phase Angle for Heart Failure (HF) Hospitalization and Readmission Risk Stratification

Presenter: Kivanc Ozonat

February 11, 2025

Presentation THT Abstracts 2025

Handheld Ultrasound Reliably Measures Placement of Impella® Devices

Presenter: Miguel Woodham

February 11, 2025

Presentation THT Abstracts 2025

Leveraging Remote Patient Monitoring to Optimize Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction

Presenter: Qianlan Xi

February 11, 2025

Presentation THT Abstracts 2025

Heart Failure Management Using a Risk Score From an Insertable Cardiac Monitor: The Rationale and Design of the ALLEVIATE-HF Trial

Presenter: Javed Butler

February 11, 2025

Presentation THT Abstracts 2025

Baroreflex Activation Therapy Improves Cardiopulmonary Exercise Tolerance and Aerobic Capacity in Heart Failure With Reduced Ejection Fraction

Presenter: Dmitry Yaranov

February 11, 2025

Presentation THT Abstracts 2025

Flow Restoration Leads to LV Mass Regression After DurAVR® Biomimetic THV Implant: MRI Study

February 11, 2025

Presentation THT Abstracts 2025

Evaluating Glucagon-Like Peptide Agonists and Glucose-Dependent Insulinotropic Polypeptide Receptor Agonists Treatment in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis of Global RCTs

February 11, 2025

Presentation THT Abstracts 2025

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Presenter: Jonathan Zawadzki

February 11, 2025

Presentation THT Abstracts 2025

Navigating Conduction Abnormalities Following Transcatheter Tricuspid Valve Replacement (TTVR): A Single Center Experience

Presenter: Tooba Salar

February 11, 2025

Presentation THT Abstracts 2025

Impact of Sitagliptin on Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction in Type 2 Diabetes Patients: A Retrospective Cohort Study

Presenter: Thitiphan Srikulmontri

February 11, 2025

Advertisement

Slides

Bioelectrical Phase Angle for Heart Failure (HF) Hospitalization and Readmission Risk Stratification

Handheld Ultrasound Reliably Measures Placement of Impella® Devices

Leveraging Remote Patient Monitoring to Optimize Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction

Heart Failure Management Using a Risk Score From an Insertable Cardiac Monitor: The Rationale and Design of the ALLEVIATE-HF Trial

Baroreflex Activation Therapy Improves Cardiopulmonary Exercise Tolerance and Aerobic Capacity in Heart Failure With Reduced Ejection Fraction

Flow Restoration Leads to LV Mass Regression After DurAVR® Biomimetic THV Implant: MRI Study

Evaluating Glucagon-Like Peptide Agonists and Glucose-Dependent Insulinotropic Polypeptide Receptor Agonists Treatment in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis of Global RCTs

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Navigating Conduction Abnormalities Following Transcatheter Tricuspid Valve Replacement (TTVR): A Single Center Experience

Impact of Sitagliptin on Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction in Type 2 Diabetes Patients: A Retrospective Cohort Study

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content